Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Peptide Drug Conjugate

Vijay Narendranath

PhD

🏢Novartis Institutes for BioMedical Research🌐USA

Director, Peptide Therapeutics Discovery

25
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Vijay Narendranath has contributed to peptide therapeutics discovery including somatostatin and PSMA peptide ligands used in radioligand therapy at Novartis. His work supports the development of peptide-drug and peptide-radionuclide conjugates for prostate and neuroendocrine cancers. He is a specialist in targeted peptide delivery.

Share:

🧪Research Fields 研究领域

peptide drug conjugates
radioligand therapy
somatostatin receptor
PSMA ligands
cancer targeted delivery

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Vijay Narendranath 的研究动态

Follow Vijay Narendranath's research updates

留下邮箱,当我们发布与 Vijay Narendranath(Novartis Institutes for BioMedical Research)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment